Latest results from National Insulin Pump Audit released

By Editor
18th June 2018
Insulin pumps, Type 1 diabetes

More people with type 1 diabetes should be considered for pump treatment in line with NICE guidance, the National Insulin Pump Audit has recommended.

The latest findings from the National Diabetes Insulin Pump Audit, 2016-2017 have been published by NHS Digital.

The audit collects information on the number and characteristics of people with diabetes using an insulin pump, the reasons for going on an insulin pump and the outcomes achieved since starting the pump.

A total of 55 centres from England contributed data to the audit.

Key findings include:

  • Improved participation and data quality means that the report this year is more comprehensive and clinically useful.
  • The rate at which people with Type 1 diabetes are starting pump treatment has stabilised.
  • The proportion of people with Type 1 diabetes attending specialist services that are treated with pumps varies from >40 per cent to <5 per cent.
  • Between two thirds and three quarters of pump users are recorded as achieving their pump treatment goals.
  • Nine out of ten people reached their target goal for hypoglycaemia.
  • Seven out of ten people reached their target goal for glucose control.
  • Type 1 diabetes pump users more often achieve all their treatment targets, and on average have a lower HbA1c, than their non-pump using peers.

Recommendations from the reports include:

  • The variation in provision and apparent benefit suggests that more people with type 1 diabetes should be considered for pump treatment in line with NICE guidance.
    • Who: all services delivering type 1 diabetes care.
    • What: offer pump therapy to all people with type 1 diabetes who meet NICE criteria.
    • Where/when: during annual, or more frequent, review with named doctor or nurse.
  • The ten fold variation between specialist centres in pump use by people with type 1 diabetes suggests a lack of access for patients attending some services and should be investigated.
    • Who: all specialist services and commissioners.
    • What: consider whether there is adequate understanding, capacity and capability to explain and provide pump treatment.
    • Where/when: during National Diabetes Audit review and action planning.

To access the summary report, click here.

Comments (0)

Register an account or login to comment